SLC7A11 and lung cancer: The antiporter xCT, which exports glutamate and imports cysteine into the cells, has been implicated in the proliferation, metastasis, and multidrug resistance of several types of cancer (44, 52, 53) and has been identified as a potential therapeutic target in lung cancer (54, 55).